GlaxoSmithKline To Quit Paying Doctors For Promotional Talks

The company will no longer hire doctors to promote its drugs and will stop tying drug rep pay to number of prescriptions written.

Charles Ornstein
By Charles Ornstein

In a major departure from industry practice, GlaxoSmithKline, the sixth-largest global drug maker, announced Tuesday that it will no longer hire doctors to promote its drugs. The company also will stop tying compensation for sales representatives to the number of prescriptions written for drugs they market. The changes will be made worldwide

Read Full Article

Seizure Cure-All? New THC-Free Cannabis Drug In Studies

Last week the FDA approved studies of CBD, a cannabis-based drug.

Katie Rucke
By Katie Rucke
Jayden shown taking CBD meds, a derivative of marijuana. (Photo /Jason David/Facebook page: “Jason and Jayden’s Journey”)

In order to reap the health benefits of marijuana without getting the “high” from the plant’s psychoactive ingredient, many medical marijuana patients have turned to a variety of the plant that is so low in THC that it is nearly impossible to get high. Instead, the plant is high in another ingredient -- cannabidiol, or CBD, which has been

Read Full Article

FDA To Regulate Compounding Pharmacies

Increased regulation could bring an end to small compounding pharmacies in the era of Big Pharma.

Mint Press News Desk
By Mint Press News Desk

After a deadly meningitis outbreak traced to a New England compounding pharmacy killed at least 50 Americans last year, the U.S. government is poised to step in and increase regulation of these niche facilities through the Food and Drug Administration (FDA). It could shake up an entire industry struggling to recover from a string of safety and

Read Full Article